Literature DB >> 18455283

Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch.

David M Frerichs1, Larry R Ellingsworth, Sarah A Frech, David C Flyer, Christina P Villar, Jianmei Yu, Gregory M Glenn.   

Abstract

A Skin Prep System (SPS) has been developed to provide a well-tolerated and controlled method of stratum corneum disruption using mild abrasion as part of transcutaneous immunization (TCI). In this study, four groups (n=10) of volunteers were pretreated with the SPS using three different lengths of mild abrasive strips (13 mm, 25 mm and 38 mm), or a handheld applicator. They then received a vaccine patch containing 50 microg of the heat-labile enterotoxin from Escherichia coli (LT) at day 0 and day 21. Subsequent anti-LT IgG antibody responses were dependent on abrasive strip length, with highest immune responses seen after use of the longest strip. The development of a simple, single-use, disposable device that is well-tolerated and allows disruption to be modulated represents an important step forward in physical penetration enhancement for the skin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18455283     DOI: 10.1016/j.vaccine.2008.02.070

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  Cholera toxin activates nonconventional adjuvant pathways that induce protective CD8 T-cell responses after epicutaneous vaccination.

Authors:  Irlanda Olvera-Gomez; Sara E Hamilton; Zhengguo Xiao; Carla P Guimaraes; Hidde L Ploegh; Kristin A Hogquist; Liangchun Wang; Stephen C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

2.  Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.

Authors:  Gaëlle Vandermeulen; Liévin Daugimont; Hervé Richiardi; Marie-Lise Vanderhaeghen; Nathalie Lecouturier; Bernard Ucakar; Véronique Préat
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

Review 3.  An update on the use of laser technology in skin vaccination.

Authors:  Xinyuan Chen; Ji Wang; Dilip Shah; Mei X Wu
Journal:  Expert Rev Vaccines       Date:  2013-10-16       Impact factor: 5.217

Review 4.  The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review.

Authors:  Bruce J Lanser; Donald Y M Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

Review 5.  Langerhans cells as targets for immunotherapy against skin cancer.

Authors:  Patrizia Stoitzner; Florian Sparber; Christoph H Tripp
Journal:  Immunol Cell Biol       Date:  2010-03-30       Impact factor: 5.126

6.  Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization.

Authors:  Alexander K Andrianov; Daniel P DeCollibus; Helice A Gillis; Henry H Kha; Alexander Marin; Mark R Prausnitz; Lorne A Babiuk; Hugh Townsend; George Mutwiri
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

7.  Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.

Authors:  Xinyuan Chen; Dilip Shah; Garuna Kositratna; Dieter Manstein; Richard R Anderson; Mei X Wu
Journal:  J Control Release       Date:  2012-01-09       Impact factor: 9.776

8.  [Allergen specific immunotherapy for rhinitis allergica : New applications].

Authors:  L Klimek; T Kündig; G Senti
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

Review 9.  New routes for allergen immunotherapy.

Authors:  Pål Johansen; Seraina von Moos; Deepa Mohanan; Thomas M Kündig; Gabriela Senti
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

10.  Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

Authors:  Behazine Combadière; Annika Vogt; Brice Mahé; Dominique Costagliola; Sabrina Hadam; Olivia Bonduelle; Wolfram Sterry; Shlomo Staszewski; Hans Schaefer; Sylvie van der Werf; Christine Katlama; Brigitte Autran; Ulrike Blume-Peytavi
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.